Intuitive Surgical (ISRG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
Intuitive Surgical (ISRG -8.61%) was a pioneer in minimally invasive robotic-assisted surgery technology, and its leadership in the field has long been a key edge for the company. Thanks to strong sales growth and climbing profitability over the past two decades, it has rewarded long-term shareholders handsomely: The stock has returned a staggering 24,632% since its 2003 initial public offering.
The Nasdaq Composite (^IXIC 0.87%) and the S&P 500 (^GSPC 0.67%) sank, shifting in and out of correction territory in the first quarter of the year for one big reason: investors have been worried about the economy. President Donald Trump is putting tariffs on imports, and economists predict this could lead to higher inflation and a slowdown in growth.
Intuitive Surgical (ISRG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Explore the exciting world of Intuitive Surgical (ISRG -3.12%) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
Investing in surgical robotics stocks like ISRG, ZBH and STXS can be profitable for investors in 2025.
Intuitive Surgical (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Robotic surgery has transformed the healthcare sector, improving patient treatment and outcomes. Intuitive Surgical (ISRG 1.63%) builds and sells the da Vinci, a robotic system used for various surgical procedures.
Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $492.06, signifying a +1.68% move from its prior day's close.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Intuitive Surgical's ISRG recent device recall for its latest robotic surgery system, da Vinci 5, has been categorized by the FDA as a Class 2 recall, a grade below the most serious Class I recalls.